CLINICAL RESEARCH
Trabecular bone score and 3D-DXA in young, antiretroviral treatment-naïve patients in Madrid
 
More details
Hide details
1
Division of Infectious Diseases, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain
 
2
Metabolic Bone Diseases Unit, Internal Medicine Department, IIS-Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain
 
3
Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz. Universidad Autónoma de Madrid, Madrid, Spain
 
 
Submission date: 2021-02-01
 
 
Final revision date: 2021-03-03
 
 
Acceptance date: 2021-03-21
 
 
Publication date: 2021-05-05
 
 
Arch Med Sci Civil Dis 2021;6(1):52-60
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Low bone mineral density (BMD) has been described as a non-AIDS-related event in human immunodeficiency virus (HIV)-patients, but it is poorly studied by dual-energy X-ray absorptiometry (DXA) and trabecular bone score (TBS) in young HIV-infected men who have received no previous antiretroviral treatment (ART).

Material and methods:
A retrospective study of 56 naïve-HIV-infected men under 50 years old with recently diagnosed HIV infection, between May 2012 and July 2017.

Results:
The mean age was 33.11 ±6.6 years, and they were 56.4% Caucasian and 43.6% Latin American. Regarding lifestyle and risk factors, 57% had previous exposure to tobacco and 31% reported drug use. Low BMD (Z-score < –2.0) was found in 21.4% of the patients, and partially degraded and degraded in 25% and 1.7%, respectively in TBS. We find significative prevalence of bone involvement among naïve HIV-infected men under 50 years old.

Conclusions:
Further studies are necessary to evaluate if BMD assessment should be recommended in young HIV-infected patients.

 
REFERENCES (26)
1.
Brooks JT, Buchacz K, Gebo KA, Mermin J. HIV infection and older Americans: the public health perspective. Am J Public Health 2012; 102: 1516-26.
 
2.
Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 2007; 21: 617-23.
 
3.
Haskelberg H, Carr A, Emery S. Bone turnover markers in HIV disease. AIDS Rev 2011; 13: 240-50.
 
4.
Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab 2008; 93: 3499-504.
 
5.
Sharma A, Flom PL, Weedon J, Klein RS. Prospective study of bone mineral density. AIDS 2011; 24: 2337-45.
 
6.
Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 1254-9.
 
7.
Silva BC, Boutroy S, Zhang C, et al. Trabecular bone score (TBS): a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2013; 98: 1963-70.
 
8.
Silverberg SJ, Clarke BL, Peacock M, et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99: 3580-94.
 
9.
Silva BC, Leslie WD, Resch H, et al. Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 2014; 29: 518-30.
 
10.
McCloskey EV, Odén A, Harvey NC, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res 2016; 31: 940-8.
 
11.
World Health Organization. Assesment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO. Technical report series. Ginebra. Suiza 1994.
 
12.
2019 ISCD Official Positions – Adult – International Society for Clinical Densitometry (ISCD). Available at: http://www.iscd.org/official-p... October 28, 2019].
 
13.
Young B, Dao CN, Buchacz K, Baker R, Brooks JT. Increased rates of bone fracture among HIV-infected persons in the HIV outpatient study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis 2011; 52: 1061-8.
 
14.
Güerri-Fernández R, Molina D, Villar-García J, et al. Brief Report: HIV Infection Is Associated with Worse Bone Material Properties, Independently of Bone Mineral Density. J Acquir Immune Defic Syndr 2016; 72:314–8.
 
15.
Güerri-Fernandez R, Vestergaard P, Carbonell C, et al. HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. J Bone Miner Res 2013; 28: 1259-63.
 
16.
Prieto-Alhambra D, Güerri-Fernández R, De Vries F, et al. HIV infection and its association with an excess risk of clinical fractures. JAIDS J Acquir Immune Defic Syndr 2014; 66: 90-5.
 
17.
Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20: 2165-74.
 
18.
Ciullini L, Pennica A, Argento G, et al. Trabecular bone score (TBS) is associated with sub-clinical vertebral fractures in HIV-infected patients. J Bone Miner Metab 2018; 36: 111-8.
 
19.
Paccou J, Viget N, Drumez E, Cortet B, Robineau O. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men. Médecine Mal Infect 2018; 48: 442-8.
 
20.
Dave JA, Cohen K, Micklesfield LK, Maartens G, Levitt NS. Antiretroviral therapy, especially efavirenz, is associated with low bone mineral density in HIV-infected South Africans. PLoS One 2015; 10: e0144286.
 
21.
Güerri-Fernández R, Lerma-Chippirraz E, Fernandez Marron A, et al. Bone density, microarchitecture, and tissue quality after 1 year of treatment with tenofovir disoproxil fumarate. AIDS Lond Engl 2018; 32: 913-20.
 
22.
Yin MT, Lund E, Shah J, et al. Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS 2014; 28: 345-53.
 
23.
Fonollà R, Nogues X, Malouf J, Romera J HL. Datos de referencia para medidas del hueso cortical y trabecular mediante la tecnología 3D-DXA. SEIOMM 2016; 8: 29.
 
24.
Kužma M, Vaňuga P, Ságova I, et al. Non-invasive DXA-derived bone structure assessment of acromegaly patients: a cross-sectional study. Eur J Endocrinol 2019; 180: 201-11.
 
25.
García Hoyos M, Humbert L, Salmón Z, Riancho JA, Valero C. Analysis of volumetric BMD in people with Down syndrome using DXA-based 3D modeling. Arch Osteoporos 2019; 14: 98.
 
26.
Ceballos ME, Carvajal C, Jaramillo J, Dominguez A, González G. Vitamin D and bone mineral density in HIV newly diagnosed therapy-naive patients without any secondary causes of osteoporosis. Calcif Tissue Int 2019; 104: 42-9.
 
ISSN:2451-0637
Journals System - logo
Scroll to top